Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Roth, M. Tamm (Basel, Switzerland). Omalizumab inhibits IgE-induced extracellular matrix deposition by asthmatic airway smooth muscle cells. Eur Respir J 2011; 38: Suppl. 55, 743

Member's Comments

No comment yet.

Related content which might interest you: IgE-induced pro-inflammatory extracellular matrix composition in airway smooth muscle cells is prevented by omalizumab Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Production of extracellular matrix proteins by asthmatic airway smooth muscle cells in culture Source: Eur Respir J 2002; 20: Suppl. 38, 383s Year: 2002 Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008 TGFβ1-induced extracellular matrix production enhances airway smooth muscle cell proliferation Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 The extracellular matrix deposited by asthmatic airway smooth muscle cells in a resting state reflects a healthy matrix Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Increased activation of TGF-β by asthmatic airway smooth muscle cells via integrin αVβ5 Source: Annual Congress 2009 - Airway cell biology Year: 2009 Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Asthmatic and non-asthmatic airway smooth muscle production of the mast cell chemotaxin CXCL10 involves MAPK Source: Eur Respir J 2006; 28: Suppl. 50, 854s Year: 2006 Regulation of human airway smooth muscle migration and matrix production by PPAR-ligands Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006 Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 342s Year: 2005 Extracellular matrix regulates human airway smooth muscle cell migration Source: Eur Respir J 2004; 24 : 545-551 Year: 2004 Extracellular matrix within the airway smooth muscle layer in COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Tocotrienol inhibits TGF-beta1-induced human airway smooth muscle cell differentiation Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Contribution of bronchial smooth muscle to inflammation Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease Year: 2005 Upregulation of airway smooth muscle (ASM) cell apoptosis may limit ASM growth during airway remodeling in experimental asthma Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008 Extracellular matrix components and regulators in the airway smooth muscle in asthma Source: Eur Respir J 2008; 32: 61-69 Year: 2008